title: Alveolar soft part sarcoma with lung metastases. Response to interferon alpha-2a?
authors.forename: K
authors.initials: K
authors.lastname: Kuriyama
authors.forename: S
authors.initials: S
authors.lastname: Todo
authors.forename: S
authors.initials: S
authors.lastname: Hibi
authors.forename: A
authors.initials: A
authors.lastname: Morimoto
authors.forename: S
authors.initials: S
authors.lastname: Imashuku
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008297:Male; D011379:Prognosis; D012509:Sarcoma / Q000188:drug therapy* / Q000556:secondary*; D012983:Soft Tissue Neoplasms / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha